These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9342375)

  • 1. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.
    Malech HL; Maples PB; Whiting-Theobald N; Linton GF; Sekhsaria S; Vowells SJ; Li F; Miller JA; DeCarlo E; Holland SM; Leitman SF; Carter CS; Butz RE; Read EJ; Fleisher TA; Schneiderman RD; Van Epps DE; Spratt SK; Maack CA; Rokovich JA; Cohen LK; Gallin JI
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12133-8. PubMed ID: 9342375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
    Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
    Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.
    Brenner S; Whiting-Theobald NL; Linton GF; Holmes KL; Anderson-Cohen M; Kelly PF; Vanin EF; Pilon AM; Bodine DM; Horwitz ME; Malech HL
    Blood; 2003 Oct; 102(8):2789-97. PubMed ID: 12829597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic correction of p67phox deficient chronic granulomatous disease using peripheral blood progenitor cells as a target for retrovirus mediated gene transfer.
    Weil WM; Linton GF; Whiting-Theobald N; Vowells SJ; Rafferty SP; Li F; Malech HL
    Blood; 1997 Mar; 89(5):1754-61. PubMed ID: 9057660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial.
    Kang HJ; Bartholomae CC; Paruzynski A; Arens A; Kim S; Yu SS; Hong Y; Joo CW; Yoon NK; Rhim JW; Kim JG; Von Kalle C; Schmidt M; Kim S; Ahn HS
    Mol Ther; 2011 Nov; 19(11):2092-101. PubMed ID: 21878903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term high-level reconstitution of NADPH oxidase activity in murine X-linked chronic granulomatous disease using a bicistronic vector expressing gp91phox and a Delta LNGFR cell surface marker.
    Sadat MA; Pech N; Saulnier S; Leroy BA; Hossle JP; Grez M; Dinauer MC
    Hum Gene Ther; 2003 May; 14(7):651-66. PubMed ID: 12804147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells.
    Ujhelly O; Ozvegy C; Várady G; Cervenak J; Homolya L; Grez M; Scheffer G; Roos D; Bates SE; Váradi A; Sarkadi B; Német K
    Hum Gene Ther; 2003 Mar; 14(4):403-12. PubMed ID: 12659681
    [No Abstract]   [Full Text] [Related]  

  • 8. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
    Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
    Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.
    Dunbar CE; Kohn DB; Schiffmann R; Barton NW; Nolta JA; Esplin JA; Pensiero M; Long Z; Lockey C; Emmons RV; Csik S; Leitman S; Krebs CB; Carter C; Brady RO; Karlsson S
    Hum Gene Ther; 1998 Nov; 9(17):2629-40. PubMed ID: 9853529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral gene therapy for X-linked chronic granulomatous disease.
    Kohn DB; Booth C; Kang EM; Pai SY; Shaw KL; Santilli G; Armant M; Buckland KF; Choi U; De Ravin SS; Dorsey MJ; Kuo CY; Leon-Rico D; Rivat C; Izotova N; Gilmour K; Snell K; Dip JX; Darwish J; Morris EC; Terrazas D; Wang LD; Bauser CA; Paprotka T; Kuhns DB; Gregg J; Raymond HE; Everett JK; Honnet G; Biasco L; Newburger PE; Bushman FD; Grez M; Gaspar HB; Williams DA; Malech HL; Galy A; Thrasher AJ;
    Nat Med; 2020 Feb; 26(2):200-206. PubMed ID: 31988463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization and transduction of CD34(+) peripheral blood stem cells in patients with X-linked chronic granulomatous disease.
    Ott MG; Merget-Millitzer H; Ottmann OG; Martin H; Brüggenolte N; Bialek H; Seger R; Hossle JP; Hoelzer D; Grez M
    J Hematother Stem Cell Res; 2002 Aug; 11(4):683-94. PubMed ID: 12201957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-selected complete restoration of superoxide generation in Epstein-Barr virus-transformed B cells from p47phox-deficient chronic granulomatous disease patients by using a bicistronic retrovirus vector encoding a human multi-drug resistance gene (MDR1) and the p47phox gene.
    Iwata M; Nunoi H; Matsuda I; Kanegasaki S; Tsuruo T; Sugimoto Y
    Hum Genet; 1998 Oct; 103(4):419-23. PubMed ID: 9856484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
    Nunoi H; Ishibashi F
    Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease.
    Mardiney M; Jackson SH; Spratt SK; Li F; Holland SM; Malech HL
    Blood; 1997 Apr; 89(7):2268-75. PubMed ID: 9116268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
    Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-generated p47
    Wrona D; Siler U; Reichenbach J
    Sci Rep; 2017 Mar; 7():44187. PubMed ID: 28287132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic granulomatous disease: towards gene therapy.
    Thrasher A; Segal A; Casimir C
    Immunodeficiency; 1993; 4(1-4):327-33. PubMed ID: 8167728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
    Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
    J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.
    Zentilin L; Tafuro S; Grassi G; Garcia R; Ventura A; Baralle F; Falaschi A; Giacca M
    Exp Cell Res; 1996 Jun; 225(2):257-67. PubMed ID: 8660913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.